Table 2.

Prevalence estimates of depression, anxiety and resilience (as measured by PHQ 9, GAD-7 and CD-RISC 10 scales) among the participants by covid-19 impact

Psychometric property	Impacted by Covid-19 N (%)	Not Impacted by Covid-19 N (%)	Total sample N (%)
Depression as measured by PHQ-9
Minimal to mild depression (score ≤ 9)	398 (56.2)	74 (82.2)	472 (59.1)
Moderate to severe depression (score ≥ 10)	310 (43.8)	16 (17.8)	326 (40.9)
Anxiety as measured by GAD-7
Minimal to mild anxiety (score ≤ 9)	424 (59.9)	62 (68.9)	486 (60.9)
Moderate to severe anxiety (Score ≥ 10)	284 (40.1)	28 (31.8)	312 (39.1)
Resilience as measured by CD-RISC-10
Low to normal resilience (≤ 32)	631 (89.1)	75 (83.3)	706 (88.5)
High resilience (score ≥ 33)	77 (10.9)	15 (16.7)	92 (11.5)
Total	708 (100)	90 (100)	798 (100)

PHQ-9 patient health questionnaire, GAD-7 generalized anxiety disorder-7, CD-RISC-10 Connor–Davidson Resilience Scale